Showing results (81-90 of 406) with videos related to

Sort By:
Pageof 41
Blood|April 26, 2003
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemiaHelmut Rainer Salih, Holger Antropius, Friederike Gieseke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2003
Expression of her-2/neu on acute lymphoblastic leukemias: implications for the development of immunotherapeutic approachesMartin R Müller, Frank Grünebach, Katrin Kayser, et al.
Experimental Hematology|December 13, 2006
Haploidentical allogeneic hematopoietic cell transplantation in adults with reduced-intensity conditioning and CD3/CD19 depletion: fast engraftment and low toxicityWolfgang A Bethge, Matthias Haegele, Christoph Faul, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2009
The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cellsAndreas M Boehmler, Adriana Drost, Lena Jaggy, et al.
Blood|February 17, 2009
Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemiaTamara Riedt, Martin Ebinger, Helmut R Salih, et al.
Annals of the New York Academy of Sciences|October 3, 2009
Hematopoietic development from human induced pluripotent stem cellsClaudia Lengerke, Matthias Grauer, Nina I Niebuhr, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2013
Management of disseminated intravascular coagulopathy with direct factor Xa inhibitor rivaroxaban in Klippel-Trénaunay syndromeElko Randrianarisoa, Hans-Georg Kopp, Bernd M Balletshofer, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2010
Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donorsHans-Georg Kopp, Stefan Wirths, Christoph Faul, et al.
Blood Cancer Journal|January 10, 2020
Comparison of three different serum-free light-chain assays-implications on diagnostic and therapeutic monitoring of multiple myelomaAneta Schieferdecker, Sebastian Hörber, Monika Ums, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 8, 2023
A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide ExposureFaith E Davies, Xavier Leleu, Prisca Vogel, et al.
Pageof 41